PML-RARA can increase hematopoietic self-renewal without causing a myeloproliferative disease in mice

Journal of Clinical Investigation

Volumn 121, Issue 4, 2011, Pages 1636-1645

  Welch, John S ^a   Yuan, Wenlin ^a   Ley, Timothy J ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROMYELOCYTIC LEUKEMIA PROTEIN; RETINOIC ACID RECEPTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BONE MARROW; CELL PROLIFERATION; CELL RENEWAL; DISEASE COURSE; FEEDBACK SYSTEM; FEMALE; GENE LOCUS; HEMATOPOIESIS; HEMATOPOIETIC CELL; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; MALE; MOUSE; MUTATIONAL ANALYSIS; MYELOPROLIFERATIVE DISORDER; NONHUMAN; PRIORITY JOURNAL; PROMYELOCYTIC LEUKEMIA; PROTEIN EXPRESSION; TITRIMETRY;

ANIMALS; BASE SEQUENCE; DISEASE MODELS, ANIMAL; DNA PRIMERS; FEEDBACK, PHYSIOLOGICAL; FEMALE; GENE EXPRESSION; HEMATOPOIESIS; HOMEOSTASIS; HUMANS; LEUKEMIA, PROMYELOCYTIC, ACUTE; MALE; MICE; MICE, INBRED C57BL; MICE, MUTANT STRAINS; MYELOPROLIFERATIVE DISORDERS; ONCOGENE PROTEINS, FUSION; PREGNANCY; RNA, MESSENGER; SPECIES SPECIFICITY;

EID: 79953323643     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI42953     Document Type: Article

References (38)

1. Jurcic JG, Soignet SL, Maslak AP. Diagnosis and treatment of acute promyelocytic leukemia. Curr Oncol Rep. 2007;9(5):337-344. (Pubitemid 47377064)
2. Borrow J, et al. Diagnosis of acute promyelocytic leukaemia by RT-PCR: detection of PML-RARA and RARA-PML fusion transcripts. Br J Haematol. 1992;82(3):529-540.
3. Kogan SC. Mouse models of acute promyelocytic leukemia. Curr Top Microbiol Immunol. 2007;313:3-29. (Pubitemid 47400330)
4. Westervelt P, Ley TJ. Seed versus soil: the importance of the target cell for transgenic models of human leukemias. Blood. 1999;93(7):2143-2148. (Pubitemid 29153613)
5. Grignani F, et al. PML/RAR alpha fusion protein expression in normal human hematopoietic progenitors dictates myeloid commitment and the promyelocytic phenotype. Blood. 2000;96(4):1531-1537. (Pubitemid 30658487)
6. Brown D, et al. A PMLRARalpha transgene initiates murine acute promyelocytic leukemia. Proc Natl Acad Sci U S A. 1997;94(6):2551-2556. (Pubitemid 27136913)
7. Westervelt P, et al. High-penetrance mouse model of acute promyelocytic leukemia with very low levels of PML-RARalpha expression. Blood. 2003;102(5):1857-1865. (Pubitemid 37022583)
8. Grisolano JL, Wesselschmidt RL, Pelicci PG, Ley TJ. Altered myeloid development and acute leukemia in transgenic mice expressing PML-RAR alpha under control of cathepsin G regulatory sequences. Blood. 1997;89(2):376-387. (Pubitemid 27051671)
9. He LZ, et al. Acute leukemia with promyelocytic features in PML/RARalpha transgenic mice. Proc Natl Acad Sci U S A. 1997;94(10):5302-5307.
10. Liang D, et al. Expressions of Raldh3 and Raldh4 during zebrafish early development. Gene Expr Patterns. 2008;8(4):248-253.
11. Rego EM, Wang ZG, Peruzzi D, He LZ, Cordon-Cardo C, Pandolfi PP. Role of promyelocytic leukemia (PML) protein in tumor suppression. J Exp Med. 2001;193(4):521-529. (Pubitemid 32524482)
12. Frohling S, Dohner H. Chromosomal abnormalities in cancer. N Engl J Med. 2008;359(7):722-734.
13. Tomasson MH, et al. Somatic mutations and germline sequence variants in the expressed tyrosine kinase genes of patients with de novo acute myeloid leukemia. Blood. 2008;111(9):4797-4808.
14. Purton LE, et al. RARgamma is critical for maintaining a balance between hematopoietic stem cell self-renewal and differentiation. J Exp Med. 2006;203(5):1283-1293. (Pubitemid 43736597)
15. Chan IT, et al. Conditional expression of oncogenic K-ras from its endogenous promoter induces a myeloproliferative disease. J Clin Invest. 2004;113(4):528-538. (Pubitemid 38542502)
16. UniGene: Organized View of the Transcriptome. http://www.ncbi.nlm.nih. gov/unigene/. Accessed February 18, 2011.
17. Lane AA, Ley TJ. Neutrophil elastase is important for PML-retinoic acid receptor alpha activities in early myeloid cells. Mol Cell Biol. 2005;25(1):23-33. (Pubitemid 40044789)
18. Ferrucci PF, Grignani F, Pearson M, Fagioli M, Nicoletti I, Pelicci PG. Cell death induction by the acute promyelocytic leukemia-specific PML/RARalpha fusion protein. Proc Natl Acad Sci U S A. 1997;94(20):10901-10906.
19. Grignani F, et al. The acute promyelocytic leukemia-specific PML-RAR alpha fusion protein inhibits differentiation and promotes survival of myeloid precursor cells. Cell. 1993;74(3):423-431. (Pubitemid 23244608)
20. Clausen BE, Burkhardt C, Reith W, Renkawitz R, Forster I. Conditional gene targeting in macrophages and granulocytes using LysMcre mice. Transgenic Res. 1999;8(4):265-277. (Pubitemid 29523965)
21. Ye M, et al. Hematopoietic stem cells expressing the myeloid lysozyme gene retain long-term, multilineage repopulation potential. Immunity. 2003;19(5):689-699. (Pubitemid 37490794)
22. Hayashi S, McMahon AP. Efficient recombination in diverse tissues by a tamoxifen-inducible form of Cre: a tool for temporally regulated gene activation/inactivation in the mouse. Dev Biol. 2002;244(2):305-318. (Pubitemid 34450645)
23. Higashi AY, et al. Direct hematological toxicity and illegitimate chromosomal recombination caused by the systemic activation of CreERT2. J Immunol. 2009;182(9):5633-5640.
24. Welch JS, Klco JM, Varghese N, Nagarajan R, Ley TJ. Rara haploinsufficiency modestly influences the phenotype of APL [published online ahead of print December 29, 2010]. Blood. doi:blood-2010-08-300087v1-blood-2010- 08-300087.
25. Uy GL, Lane AA, Welch JS, Grieselhuber NR, Payton JE, Ley TJ. A protease-resistant PML-RAR{alpha} has increased leukemogenic potential in a murine model of acute promyelocytic leukemia. Blood. 2010;116(18):3604-3610.
26. Turhan A, et al. Highly purified primitive hematopoietic stem cells are PML-RARA negative and generate nonclonal progenitors in acute promyelocytic leukemia. Blood. 1995;85(8):2154-2161.
27. Wojiski S, et al. PML-RARalpha initiates leukemia by conferring properties of self-renewal to committed promyelocytic progenitors. Leukemia. 2009;23(8):1462-1471.
28. Guibal FC, et al. Identification of a myeloid committed progenitor as the cancer-initiating cell in acute promyelocytic leukemia. Blood. 2009;114(27):5415-5425.
29. Bonnet D, Dick JE. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med. 1997;3(7):730-737. (Pubitemid 27298715)
30. Zhu J, et al. A sumoylation site in PML/RARA is essential for leukemic transformation. Cancer Cell. 2005;7(2):143-153. (Pubitemid 40248340)
31. Pandolfi PP. Acute myelocytic leukemia. I. Transgenic models of acute myeloid leukemias. In: Hematology 1997: Education Program of the American Society for Hematology. San Diego, California, USA: 1997.
32. Early E, et al. Transgenic expression of PML/RARalpha impairs myelopoiesis. Proc Natl Acad Sci U S A. 1996;93(15):7900-7904. (Pubitemid 26277136)
33. Wartman LD, et al. Conserved progression mutations revealed by sequencing a mouse acute promyelocytic leukemia genome. J Clin Invest. 2001;121(4):1445-1455.
34. Walter MJ, et al. Expression profiling of murine acute promyelocytic leukemia cells reveals multiple model-dependent progression signatures. Mol Cell Biol. 2004;24(24):10882-10893. (Pubitemid 39603143)
35. Funk RK, et al. Quantitative trait loci associated with susceptibility to therapy-related acute murine promyelocytic leukemia in hCG-PML/RARA transgenic mice. Blood. 2008;112(4):1434-1442.
36. Walter MJ, et al. Reduced PU.1 expression causes myeloid progenitor expansion and increased leukemia penetrance in mice expressing PML-RARalpha. Proc Natl Acad Sci U S A. 2005;102(35):12513-12518. (Pubitemid 41266390)
37. Payton JE, et al. High throughput digital quantification of mRNA abundance in primary human acute myeloid leukemia samples. J Clin Invest. 2009;119(6):1714-1726.
38. Yuan W, et al. Commonly dysregulated genes in murine APL cells. Blood. 2007;109(3):961-970. (Pubitemid 46220640)